Dulaglutide (Trulicity) and cannabis — GLP-1 receptor agonist interaction profile covering gastric emptying, edible timing, and GI considerations.
Trulicity (dulaglutide inj.)+Cannabis / THC
⚠️
Caution Advised
Dulaglutide + Cannabis (THC/CBD)
No published clinical trials exist on this combination. As a GLP-1 receptor agonist, dulaglutide delays gastric emptying creating edible cannabis timing concerns consistent with the GLP-1 class. Discuss with your prescriber.
What This Means
In Plain Language
Dulaglutide (Trulicity) is a weekly injectable GLP-1 receptor agonist. Like other GLP-1 medications, it delays gastric emptying and may affect edible cannabis absorption timing. No cannabis-specific interaction data exists for dulaglutide. The general GLP-1 class caution regarding edible timing and additive GI effects applies.
Clinical Considerations
Key Risks & Factors
Gastric emptying delay and edible timing: Dulaglutide delays gastric emptying. Edible cannabis absorption may be unpredictably delayed.
Additive GI effects: Both dulaglutide and cannabis can cause nausea. Combined effects may worsen GI symptoms during titration.
No clinical trial data: No published studies on dulaglutide and cannabis co-administration exist.
Conservative Safety Assessment
Dulaglutide shares the GLP-1 class mechanism that warrants cannabis caution — primarily edible timing unpredictability. This 'Caution Advised' classification is consistent with other GLP-1 receptor agonists. Reviewed and audited by Sanford A. Orloff, RPh (ret).
Enter all your medications, supplements, and lifestyle substances to see a complete pharmacist-reviewed interaction report — free, no account required.
Pharmacist-reviewed · FDA & NIH sources only · Always free
👨⚕️
Sanford A. Orloff, RPh (ret)
Registered Pharmacist · 40+ Years Clinical Experience · NPI 1518289974
Every interaction profile on InteractSafe is reviewed for editorial accuracy by a retired pharmacist with over 40 years of clinical experience in medication therapy management, patient counseling, and pharmaceutical care.
No clinical trial has studied this combination. Dulaglutide shares the same GLP-1 mechanism as other medications in this class, including gastric emptying delay that affects edible cannabis timing. Discuss cannabis use with your prescribing physician.
This profile is for educational purposes only. Reviewed for editorial accuracy by Sanford A. Orloff, RPh (ret).
It is NOT medical advice and does not replace consultation with a licensed physician or pharmacist.
Never change your medication routine based on this information alone.
Read Full Safety Terms →